Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Cardiovascular Syst (CSII)

Cardiovascular Syst (CSII)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Cardiovascular Syst 1225 OLD HWY 8 NW ST. PAUL MN 55112 USA

www.csi360.com P: 651-259-1600 F: 612-677-3355

Description:

Cardiovascular Systems, Inc. is a medical device manufacturer that develops and commercializes innovative solutions to treat patients suffering from peripheral and coronary arterial diseases, including those with arterial calcium. The foundation of the company's business is catheter-based platforms, which are capable of treating a wide spectrum of vessel sizes and plaque types. The company sells its products through direct sales force in the United States. The company delivers a unique, patented Orbital Atherectomy System of products that remove calcified and fibrotic plaque in arterial vessels throughout the leg and heart in very short treatment time. These products address many of the limitations associated with standard surgical, catheter and pharmacological treatment alternatives. The company is investing in sales, marketing, medical education, clinical studies and product research and development for its next phase of growth in the peripheral market and continue the commercialization of its CAD System.

Key Statistics

Overview:

Market Capitalization, $K 843,960
Enterprise Value, $K 704,430
Shares Outstanding, K 42,198
Annual Sales, $ 236,220 K
Annual Net Income, $ -36,930 K
Last Quarter Sales, $ 61,450 K
Last Quarter Net Income, $ -7,890 K
60-Month Beta 0.74
% of Insider Shareholders 3.80%
% of Institutional Shareholders 86.61%
Float, K 40,594
% Float 96.20%
Short Volume Ratio 0.64

Growth:

1-Year Return 0.15%
3-Year Return -50.37%
5-Year Return -24.92%
5-Year Revenue Growth 15.28%
5-Year Earnings Growth -3,233.33%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.20 on 02/08/23
Next Earnings Date 05/03/23
Earnings Per Share ttm -0.97
EPS Growth vs. Prev Qtr 25.93%
EPS Growth vs. Prev Year 13.04%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-10 on 02/26/09

CSII Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -15.39%
Return-on-Assets % -11.92%
Profit Margin % -15.63%
Debt/Equity 0.08
Price/Sales 3.57
Price/Cash Flow N/A
Price/Book 3.50
Book Value/Share 5.72
Interest Coverage -21.47
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar